HK$ 12.57
Key Takeaways
Risk factor
Limited default risk
Profitability factor
Very strong margins and returns
About
The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs,...
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, of fair va
Target Price
The average target price of 3933.HK is 17 and suggests 36% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
